Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

PHASE3CompletedINTERVENTIONAL
Enrollment

1,913

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions
Multiple Myeloma
Interventions
DRUG

lenalidomide

Lenalidomide, 5 mg to 25 mg, QD, orally, for 21 days every 28 days, with or without dexamethasone

DRUG

dexamethasone

Dexamethasone, 20 mg to 40 mg, QD, orally, administered under a variety of dosing regimens

Trial Locations (69)

10011

St. Vincent's Comprehensive Cancer Center, New York

10021

NY Presbyterian Hospital/Weill Medical College-Cornell University, New York

10466

New York Medical Center, MBCCOP, The Bronx

11203

SUNY Health Science Center - Brooklyn, Brooklyn

11733

North Shore Hematology/Oncology Associates, PC, East Setauket

13210

SUNY Upstate Medical University, Syracuse

15224

Western Pennsylvania Cancer Institute, Pittsburgh

15232

University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania Cancer Center, Philadelphia

19713

Delaware Clinical & Laboratory Physicians, PA, Newark

20817

Center for Cancer And Blood Disorders, Bethesda

23298

Medical College of Virginis, North Hospital, Richmond

28203

Carolinas Hematology-Oncology Associates, Charlotte

29210

South Carolina Oncology Assoc, Columbia

29403

Charleston Hematology/Oncology P.A., Charleston

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

32120

Kaiser Permanente Medical Group, San Diego

33136

University of Miami Medical School, Miami

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

33401

The Palm Beach Cancer Institute, West Palm Beach

33705

Gulf Coast Oncology, St. Petersburg

39202

Jackson Oncology Associates, Jackson

43215

Mid Ohio Oncology & Hematology, Inc., Columbus

53215

Oncology Alliance, Milwaukee

54449

Marshfield Clinic, Marshfield

54601

Gunderson Clinic, La Crosse

55905

Mayo Clinic Cancer Center, Rochester

57105

Avera Research Institute, Sioux Falls

59102

Deaconess Billings Clinic, Billings

63110

Siteman Cancer Center, St Louis

67214

Wichita CCOP, Wichita

68114

Methodist Cancer Center, Omaha

70121

Ochsner Clinic Foundation, New Orleans

77030

MD Anderson Cancer Center, Houston

80218

Rocky Mountain Cancer Center-Midtown, Denver

84112

Huntsman Cancer Institute, Salt Lake City

84124

Intermountain Hematology/Oncology, Salt Lake City

85259

Mayo Clinic, Scottsdale

89109

Nevada Cancer Center, Las Vegas

90048

Cedar Sinai Medical CenterDept of Medicine, Los Angeles

93037

Scripps Cancer Center, La Jolla

94589

Kaiser Permanente Medical Center, Vallejo

94704

Alta Bates Cancer Center, Berkeley

97227

Kaiser Permanente Northwest RegionCenter for Health Research, Portland

98104

Swedish Cancer Institute, Seattle

98109

Fred Hutchinson Cancer Research Center, Seattle

94305-5750

Stanford Cancer Center, Stanford

80045-0510

University of ColoradoHealth Science Center, Aurora

06520

Yale University School of Medicine, New Haven

06902

Hematology Oncology, PC, Stamford

33612-9497

H Lee Moffitt Cancer Center, Tampa

60611-2927

Northwestern University Med CtrDivision of Hem/Onc, Chicago

60612-3824

Rush Cancer Institute, Chicago

46202-5254

Indiana Univ Cancer Center Bone Marrow Transplantation Program Indiana Cancer Research Institute, Indianapolis

66160-7233

University of Kansas Medical Center, Kansas City

21201-1595

University of Maryland Medical Center Greenbaum Cancer Ctr, Baltimore

02115

Dana-Farber Cancer Institute, Boston

03756

Dartmouth Hitchcock Medical Center-Norris Cotton Cancer Center, Lebanon

07601

The Cancer Center at Hackensack University Medical Center, Hackensack

27157-1023

Wake Forest University School of Medicine, Winston-Salem

58108-6001

Dakota Cancer Institute, Fargo

75390-9016

University of Texas Southwestern Medical Center, Dallas

2N 4N1

University of Calgary, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E3

Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp, Vancouver

B3H2Y9

Dalhousie University Queen Elizabeth II Health Services Centre, Halifax

M5J 2M9

Princess Margaret Hospital, Toronto

H2W 1S6

McGill University, Montreal

Sponsors
All Listed Sponsors
collaborator

Prologue Research International

INDUSTRY

lead

Celgene Corporation

INDUSTRY